Annette Hasenburg

University Medical Center Freiburg, University of Freiburg

Papers

3

Total Citations

128

H-Index

3

About

Annette Hasenburg is a leading figure in gynecologic oncology, with a research focus centered on borderline ovarian tumors (BOT) and the nuanced clinical outcomes associated with this disease. Her major contributions stem from her pivotal role in the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study, a landmark investigation that has shaped modern understanding of BOT. Through this work, she has elucidated critical age-dependent differences in clinical characteristics and prognosis, demonstrating that younger patients often present with distinct tumor biology and more favorable outcomes. Furthermore, Hasenburg’s research has systematically evaluated the prognostic impact of individual surgical staging procedures, providing evidence that incomplete staging is a negative prognostic factor and clarifying which specific components of staging are most critical for patient survival. Her work has garnered significant attention, with her most cited study on age-dependent differences accumulating 75 citations. Notably, she has also advanced the field by addressing quality of life and sexual function in BOT survivors, highlighting the importance of survivorship care. Her research has established essential benchmarks for surgical management and long-term follow-up in this patient population.

Research Focus

Key Achievements

3
H-Index
3
Papers
128
Total Citations
43
Avg Citations/Paper
🏆 Most Cited Paper
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study
75 citations · 2014
📈 Most Prolific Year: 2014 (2 Papers)
🤝 Key Collaborators: 39
🏛 Institutions: University Medical Center Freiburg, University of Freiburg

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago